Muscular Dystrophy Association’s Pompe Disease Patient Focused Drug Development Meeting Cleared by FDA
source: pixabay.com

Muscular Dystrophy Association’s Pompe Disease Patient Focused Drug Development Meeting Cleared by FDA

According to a story from tradeshownews.vporoom.com, the Muscular Dystrophy Association (MDA) has recently announced the official approval of its Patient-Focused Drug Development (PFDD) meeting by the US Food and Drug…

Continue Reading Muscular Dystrophy Association’s Pompe Disease Patient Focused Drug Development Meeting Cleared by FDA
The FDA Approves New Treatment for Chronic Lymphocytic Leukemia Under an International Program
source: pixabay.com

The FDA Approves New Treatment for Chronic Lymphocytic Leukemia Under an International Program

According to a story from PR Newswire, the US Food and Drug Administration (FDA) has recently granted supplemental approval to the drug acalabrutinib (marketed as Calquence) as a treatment for…

Continue Reading The FDA Approves New Treatment for Chronic Lymphocytic Leukemia Under an International Program
An Oklahoma Medical Research Foundation Scientist Played a Critical Role in Developing a New Sickle Cell Disease Treatment
source: pixabay.com

An Oklahoma Medical Research Foundation Scientist Played a Critical Role in Developing a New Sickle Cell Disease Treatment

According to a story from The Oklahoman, Dr. Roger McEver, who is a scientist and the Vice President of Research at the Oklahoma Medical Research Foundation (OMRF), played a pioneering…

Continue Reading An Oklahoma Medical Research Foundation Scientist Played a Critical Role in Developing a New Sickle Cell Disease Treatment
The Drug Tofacitinib Appears Effective for Juvenile Idiopathic Arthritis in Clinical Trial
source: pixabay.com

The Drug Tofacitinib Appears Effective for Juvenile Idiopathic Arthritis in Clinical Trial

According to a story from Juvenile Arthritis News, the results of a recent phase 3 clinical trial indicate that the drug tofacitinib (marketed as Xeljanz) can be an effective treatment…

Continue Reading The Drug Tofacitinib Appears Effective for Juvenile Idiopathic Arthritis in Clinical Trial
New Guidelines for Vasculitis Treatment Recommend First-Line Biologics for Some Patients
source: pixabay.com

New Guidelines for Vasculitis Treatment Recommend First-Line Biologics for Some Patients

According to a story from Healio, new guidelines for the treatment of different forms of vasculitis recommend the use of biologic therapies as a first-line option for certain patients. It…

Continue Reading New Guidelines for Vasculitis Treatment Recommend First-Line Biologics for Some Patients
This Business Owner and Baker’s Daughters Will Both Benefit from Newly Covered Cystic Fibrosis Drugs
source: pixabay.com

This Business Owner and Baker’s Daughters Will Both Benefit from Newly Covered Cystic Fibrosis Drugs

According to a story from dailypost.co.uk, Richard Mason, the millionaire founder of moneysupermarket.com, and and baker Alison Faire's daughters Annabelle (aged 4 years) and Imogen (aged 7 years) don't have…

Continue Reading This Business Owner and Baker’s Daughters Will Both Benefit from Newly Covered Cystic Fibrosis Drugs
A Recent Study from Yale Tracks the Progression of Scarring in Idiopathic Pulmonary Fibrosis
source: pixabay.com

A Recent Study from Yale Tracks the Progression of Scarring in Idiopathic Pulmonary Fibrosis

According to a story from EurekAlert!, a collaborative study headed by researchers from Yale University has furthered the understanding of the mechanisms and progression of fibrosis (scarring) in patients with…

Continue Reading A Recent Study from Yale Tracks the Progression of Scarring in Idiopathic Pulmonary Fibrosis
These Two Companies Just Announced a Partnership to Develop Multiple Gene Therapies
EliasSch / Pixabay

These Two Companies Just Announced a Partnership to Develop Multiple Gene Therapies

According to a story from BioSpace, the gene therapy companies Sarepta Therapeutics, Inc. and StrideBio, Inc. have recently announced the completion of a licensing and collaboration agreement that could lead…

Continue Reading These Two Companies Just Announced a Partnership to Develop Multiple Gene Therapies
This Treatment for Multiple Sclerosis Could be on its Way to Approval in the EU
source: pixabay.com

This Treatment for Multiple Sclerosis Could be on its Way to Approval in the EU

According to a story from finanznachricten.de, the drug company Novartis recently announced that the European Medicine Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive…

Continue Reading This Treatment for Multiple Sclerosis Could be on its Way to Approval in the EU
Life as a Parent of a Child With Glycogen Storage Disease: A Rare Disease Story From the Czech Republic
source: pixabay.com

Life as a Parent of a Child With Glycogen Storage Disease: A Rare Disease Story From the Czech Republic

When your child is constantly at risk of hypoglycemia and their health and life is threatened in the case of any major problem, you have no other choice but to…

Continue Reading Life as a Parent of a Child With Glycogen Storage Disease: A Rare Disease Story From the Czech Republic
An Experimental Treatment for Rett Syndrome Earns Rare Pediatric Disease Designation
source: pixabay.com

An Experimental Treatment for Rett Syndrome Earns Rare Pediatric Disease Designation

According to a story from marketscreener.com, the biopharmaceutical company Anavex Life Sciences Corp. has announced that its experimental product candidate ANAVEX2-73 has earned Rare Pediatric Disease designation from the US…

Continue Reading An Experimental Treatment for Rett Syndrome Earns Rare Pediatric Disease Designation
Company Releases Early Clinical Data For Experimental Blood Cancer Drug
SarahMarciano / Pixabay

Company Releases Early Clinical Data For Experimental Blood Cancer Drug

According to a story from pm360online.com, the biopharmaceutical company miRagen Therapeutics, Inc., recently presented Phase I clinical trial data regarding the company's experimental drug cobomarsen. This data was presented at…

Continue Reading Company Releases Early Clinical Data For Experimental Blood Cancer Drug